These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 10958112

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G, Redman J.
    Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286
    [Abstract] [Full Text] [Related]

  • 24. The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?
    Fisk JE, Montgomery C, Wareing M, Murphy PN.
    Hum Psychopharmacol; 2006 Aug; 21(6):355-66. PubMed ID: 16915582
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.
    Fisk JE, Montgomery C, Murphy PN.
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):326-36. PubMed ID: 19803632
    [Abstract] [Full Text] [Related]

  • 30. No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study.
    Gamma A, Buck A, Berthold T, Vollenweider FX.
    J Clin Psychopharmacol; 2001 Feb; 21(1):66-71. PubMed ID: 11199950
    [Abstract] [Full Text] [Related]

  • 31. Evidence for executive deficits among users of MDMA (Ecstasy).
    Fisk JE, Montgomery C, Murphy P, Wareing M.
    Br J Psychol; 2004 Nov; 95(Pt 4):457-66. PubMed ID: 15527532
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.
    Back-Madruga C, Boone KB, Chang L, Grob CS, Lee A, Nations H, Poland RE.
    Clin Neuropsychol; 2003 Nov; 17(4):446-59. PubMed ID: 15168910
    [Abstract] [Full Text] [Related]

  • 34. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.
    Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG.
    Addiction; 2011 Apr; 106(4):777-86. PubMed ID: 21205042
    [Abstract] [Full Text] [Related]

  • 35. Deficits of long-term memory in ecstasy users are related to cognitive complexity of the task.
    Brown J, McKone E, Ward J.
    Psychopharmacology (Berl); 2010 Mar; 209(1):51-67. PubMed ID: 20119830
    [Abstract] [Full Text] [Related]

  • 36. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
    Huxster JK, Pirona A, Morgan MJ.
    J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy.
    Heffernan TM, Jarvis H, Rodgers J, Scholey AB, Ling J.
    Hum Psychopharmacol; 2001 Dec; 16(8):607-612. PubMed ID: 12404540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.